• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSB2000117 重组抗CD19m-CD3抗体注射液 A-319 Injection Biological Products(1) Supplementary Application 2020-12-02 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd In Review 2020-12-01 view
CXSL1700089 重组抗CD19m-CD3抗体注射液 A-319 Injection Biological Products(1) New Drug Application 2017-09-08 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2018-10-15 view
CXSB1600018 重组人粒细胞集落刺激因子-Fc融合蛋白注射液 Injection Biological Products Supplementary Application 2017-02-08 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2017-05-26 view
CXSB1600019 重组人粒细胞集落刺激因子-Fc融合蛋白注射液 Injection Biological Products Supplementary Application 2017-02-06 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2017-05-26 view
CXSL1300076 注射用重组人白介素22-Fc融合蛋白 Lyophilized Biological Products(1) New Drug Application 2014-01-26 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2015-11-19 view
CXSL1300043 贝格司亭 Other Biological Products(1) New Drug Application 2013-09-30 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2014-11-21 view
CXSB1200020 注射用重组人粒细胞集落刺激因子-Fc融合蛋白 Lyophilized Biological Products Supplementary Application 2013-08-28 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2014-05-16 view
CXSL1000049 注射用重组人粒细胞集落刺激因子-Fc融合蛋白 Lyophilized Biological Products(1) New Drug Application 2011-01-11 健能隆医药技术(上海)有限公司 Nutrilite Can Long Medical Technology (Shanghai) Co Ltd Certificate Issued 2012-10-30 view